ENCOMPASS HEALTH CORP's ticker is EHC and the CUSIP is 29261A100. A total of 392 filers reported holding ENCOMPASS HEALTH CORP in Q2 2019. The put-call ratio across all filers is 1.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,324 | +552.2% | 19,712 | +479.9% | 0.11% | +352.0% |
| Q4 2022 | $203 | -100.0% | 3,399 | -73.8% | 0.02% | -76.4% |
| Q4 2021 | $847,000 | +17.3% | 12,981 | +34.9% | 0.11% | +43.2% |
| Q3 2021 | $722,000 | +130.7% | 9,620 | +139.5% | 0.07% | +111.4% |
| Q2 2021 | $313,000 | -22.9% | 4,016 | -18.3% | 0.04% | -47.0% |
| Q4 2020 | $406,000 | +24.2% | 4,913 | -2.4% | 0.07% | +20.0% |
| Q3 2020 | $327,000 | +21.6% | 5,033 | +19.9% | 0.06% | -17.9% |
| Q1 2020 | $269,000 | -84.7% | 4,198 | -84.9% | 0.07% | -66.0% |
| Q2 2019 | $1,760,000 | -31.5% | 27,784 | -36.8% | 0.20% | -24.2% |
| Q1 2019 | $2,568,000 | +75.3% | 43,970 | +85.1% | 0.26% | +53.8% |
| Q4 2018 | $1,465,000 | -70.2% | 23,752 | -62.4% | 0.17% | -37.9% |
| Q3 2018 | $4,918,000 | +1656.4% | 63,090 | +1427.2% | 0.27% | +1842.9% |
| Q2 2018 | $280,000 | – | 4,131 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Paradice Investment Management LLC | 798,931 | $53,656,206 | 4.60% |
| Orchard Capital Management, LLC | 135,466 | $9,097,897 | 3.36% |
| Sivik Global Healthcare LLC | 90,000 | $6,044 | 3.05% |
| BERNZOTT CAPITAL ADVISORS | 128,663 | $8,641,007 | 2.98% |
| REINHART PARTNERS, LLC. | 746,752 | $50,151,893 | 2.60% |
| Integral Health Asset Management, LLC | 250,000 | $16,790,000 | 2.32% |
| Leeward Investments, LLC - MA | 562,001 | $37,743,987 | 1.93% |
| Copeland Capital Management, LLC | 1,277,690 | $85,809,665 | 1.84% |
| Magnetar Financial LLC | 1,060,733 | $71,238,828 | 1.82% |
| Advantage Alpha Capital Partners LP | 122,252 | $8,210,444 | 1.72% |